Long-term effectiveness of jack jumper ant venom therapy
Part of Immune system & allergy clinical trials.
This study checks how well venom immunotherapy for jack jumper ant allergy works years after treatment ends. If you finished 3–5 years of treatment and stopped 1.5 to 5 years ago, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You completed 3 to just under 6 years of jack jumper ant venom immunotherapy.
- You stopped that treatment at least 18 months ago and no more than 5 years ago.
- You can understand the study and give your permission to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.
This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.
This trial studies whether having strong reactions to a specific bee venom protein can make venom immunotherapy less effective. It may help doctors better predict who is at higher risk for therapy failure after bee stings.
This study monitors the safety of venom immunotherapy (allergy shots) for people with bee or wasp sting allergies. If you are starting this treatment, researchers will track how well you tolerate it over time.
This study looks at whether a BAT (a blood test) can stand in for sting/venom “challenges” for people already receiving venom immunotherapy. If it works, it could help patients avoid more risky or uncomfortable challenge procedures while still checking whether treatment is working.
This study tests if virtual reality experiences can affect the immune system in people with bee or wasp venom allergies. It may help understand new ways to treat allergies.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.